Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 5Recruiting 5Terminated 3

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 3Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 3Recurrence 1Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1Cholangiocarcinoma 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Clinical Protocols × Clear all
NCT06084819 2026-04-02

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Chinese PLA General Hospital

Phase 2 Recruiting
200 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06660368 2026-04-01

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting
52 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT05603884 2025-02-19

VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
66 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05557578 2025-02-11

GOT

Zhejiang Cancer Hospital

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT05378919 2022-05-18

RECTUM2015

Lithuanian University of Health Sciences

Phase 2 Recruiting
250 enrolled
Gastrointestinal

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Data powered by HemOnc (CC BY 4.0) Colophon âš¡